Organisation
Hematology
Current researchers
1 - 10 of 18 results
- Fatema Afennas (Member)
- Veerle Beckers (Member)
- Charlotte Caron (Member)
- Ludwine Antoinette Claeys (Member)
- Ann De Becker (Member)
- Nathan De Beule (Member)
- Inke De Haes (Member)
- Sylvia Faict (Member)
- Karel Fostier (Member)
- Kristin Jochmans (Member)
Projects
1 - 1 of 1
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
Publications
1 - 10 of 79
- Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics(2020)
Authors: Inke De Haes, Amélie Dendooven, Marie Le Mercier, Pauline Puylaert, Katrien Vermeulen, Mark Kockx, Kathleen Deiteren, Marie Maes, Zwi Berneman, Sébastien Anguille
Pages: 1-12 - Assessing the performance of maternity care in Europe(2015)
Authors: Ramón Escuriet, Joanna White, Katrien Beeckman, Lucy Frith, Fatima Leon-Larios, Christine Loytved, Ans Luyben, Marlene Sinclair, Edwin van Teijlingen
- Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma(2023)
Authors: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Henri Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, et al.
Pages: 1172-1177 - Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Authors: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pages: 249-255 - Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Authors: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pages: 112-121 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Authors: Julia Katharina Schwarze, Jens Tijtgat, Gil Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pages: 1-13 - Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis(2023)
Authors: Arne Van der Vreken, Inge Oudaert, Gamze Ates, Sylvia Faict, Philip Vlummens, Hatice Satilmis, Rong Fan, Anke Maes, Ann Massie, Kim De Veirman, et al.
Pages: 112-123 - Measuring antenatal care use in Europe(2017)
Authors: Katrien Beeckman, Lucy Frith, Helga Gottfreðsdóttir, Annette Bernloehr
Pages: 583-590 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Authors: Julia Katharina Schwarze, Gil Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Pages: 1-16 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pages: 20476-20489